Astera Labs (ALAB) Expected to Announce Quarterly Earnings on Tuesday

Astera Labs (NASDAQ:ALABGet Free Report) will likely be releasing its Q4 2025 results after the market closes on Tuesday, February 10th. Analysts expect Astera Labs to post earnings of $0.51 per share and revenue of $249.4620 million for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Tuesday, February 10, 2026 at 4:30 PM ET.

Astera Labs (NASDAQ:ALABGet Free Report) last released its earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. The company had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.Astera Labs’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.23 EPS. On average, analysts expect Astera Labs to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Astera Labs Trading Up 1.2%

ALAB stock opened at $152.44 on Tuesday. The stock’s 50 day simple moving average is $164.08 and its 200 day simple moving average is $172.65. Astera Labs has a 12-month low of $47.13 and a 12-month high of $262.90. The firm has a market cap of $25.75 billion, a P/E ratio of 137.33, a P/E/G ratio of 2.05 and a beta of 1.51.

Wall Street Analyst Weigh In

A number of brokerages have commented on ALAB. Stifel Nicolaus lifted their target price on Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. TD Cowen restated a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Roth Mkm upped their price objective on Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Barclays set a $165.00 target price on Astera Labs in a research note on Thursday, January 15th. Finally, Jefferies Financial Group restated a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Fifteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and an average target price of $190.63.

View Our Latest Research Report on ALAB

Insiders Place Their Bets

In related news, COO Sanjay Gajendra sold 90,459 shares of the stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the transaction, the chief operating officer owned 1,599,750 shares in the company, valued at $231,467,827.50. This represents a 5.35% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Manuel Alba sold 150,000 shares of the firm’s stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the transaction, the director directly owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. The trade was a 8.70% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 576,936 shares of company stock valued at $87,409,540. Corporate insiders own 12.50% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. CIBC Bancorp USA Inc. bought a new stake in shares of Astera Labs in the 3rd quarter worth $1,819,000. Coldstream Capital Management Inc. acquired a new position in Astera Labs during the third quarter worth about $297,000. Danske Bank A S bought a new stake in Astera Labs in the third quarter worth about $668,000. Advisory Services Network LLC lifted its holdings in Astera Labs by 33.1% in the 3rd quarter. Advisory Services Network LLC now owns 10,184 shares of the company’s stock valued at $1,994,000 after acquiring an additional 2,533 shares during the last quarter. Finally, Harvest Investment Services LLC acquired a new stake in Astera Labs in the 3rd quarter valued at about $502,000. 60.47% of the stock is owned by institutional investors.

About Astera Labs

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

Earnings History for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.